People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Pharmaceuticals, Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Moderna LLC | — | Pharmaceuticals | Growth/Late | $691.1M | $16.2B | 2014 |
| CRISPR Therapeutics AG | — | Biotech | Series B | $36.0M | $39.7M | 2020 |
James Kasinger at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Kasinger on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Ali Behbahani | 1 | 17 |
| BRADLEY BOLZON | 1 | 10 |
| Noubar Afeyan | 1 | 9 |
| Simeon George | 1 | 8 |
| Lee Babiss | 1 | 5 |
| Robert Carpenter | 1 | 5 |
| Lorence Kim | 1 | 5 |
| Stephane Bancel | 1 | 4 |
| John Mendlein | 1 | 4 |
| PETER HUTT | 1 | 4 |
| Henri Termeer | 1 | 3 |
| N. Anthony Coles | 1 | 3 |
| Tony Ho | 1 | 2 |
| Theo Melas-Kyriazi | 1 | 2 |
| Simeon J. George | 1 | 2 |
| Thomas J. Woiwode | 1 | 2 |
| John Greene | 1 | 2 |
| Rodger Novak | 1 | 1 |
| Samarth Kulkarni | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.